FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Zydus Pharmaceuticals (USA) Lansoprazole Delayed-Release Orally Recall

Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10…

Zydus Pharmaceuticals (USA) Inc · Pennington, NJ

Risk level
Class II
Reported by FDA
Nov 11, 2020
Recall ID
D-0074-2021
Check your lot numberHow we source this data

Summary

Zydus Pharmaceuticals (USA) recalled Lansoprazole Delayed-Release Orally starting Oct 27, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0074-2021 on Nov 11, 2020. Reason: Failed Dissolution Specification. Status: Terminated.

Why it was recalled

Failed Dissolution Specification

Product description

Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-771-77

Lot numbers, UPCs & expiration codes

Lot # M005681, EXP 3/2022

Where it was sold

Distributed Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0074-2021
Classification
Class II
Status
Terminated
Recall initiated
Oct 27, 2020
FDA report date
Nov 11, 2020
Quantity
6,840 units
Recall type
Voluntary: Firm initiated
Recalling firm
Zydus Pharmaceuticals (USA) Inc

Original FDA data

Every field from FDA enforcement report D-0074-2021, exactly as published.

Show all FDA fields
City
Pennington
State
NJ
Status
Terminated
Country
United States
Event ID
86663
Address
73 Route 31 N
Code information
Lot # M005681, EXP 3/2022
Postal code
08534-3601
Report date
Nov 11, 2020
Product type
Drugs
Recall number
D-0074-2021
Classification
Class II
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Product quantity
6,840 units
Termination date
Dec 20, 2022
Reason for recall
Failed Dissolution Specification
Voluntary / mandated
Voluntary: Firm initiated
Product description
Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534, NDC 68382-771-77
Distribution pattern
Distributed Nationwide in the USA
Recall initiation date
Oct 27, 2020
Initial firm notification
Letter
Center classification date
Nov 10, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0074-2021, published Nov 11, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls